“…Eighteen compounds had reported hepatocarcinogenicity in rats, of which 13 (AAA, CCL4, CFB, CMA, EE, ETN, GFZ, HCB, MCT, MP, PB, TAA, and WY) were negative for mutagenicity based on information from GENETOX or other manuscripts (Gonzalez et al, 1998;Kirkland et al, 2005;Müller-Tegethoff et al, 1995;Ohta, 1993;Schiestl and Reddy, 1990) and were defined as NGTX hepatocarcinogens in this study (Table 1). In addition, given that DAM and PBO were reported as NGTX hepatocarcinogens when used in external data sets (Okamiya et al, 1998;Xie et al, 2012), these compounds were defined as NGTX hepatocarcinogens in the present study ( (Kirkland et al, 2005;Wozniak et al, 2007) and were defined as GTX hepatocarcinogens. Forty-two compounds had no hepatocarcinogenicity and were defined as non-hepatocarcinogens (Table 2).…”